Alkem Laboratories to open trading window on June 1, 2026

1 min read     Updated on 29 May 2026, 08:30 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Alkem Laboratories has announced the opening of its trading window for designated persons on June 1, 2026. This follows the communication of the company's financial results for the quarter and year ended March 31, 2026, which were submitted to the stock exchanges on May 28, 2026. The trading window was initially closed on March 30, 2026, to comply with insider trading regulations.

powered bylight_fuzz_icon
41503920

*this image is generated using AI for illustrative purposes only.

Alkem Laboratories will open its trading window for designated persons on June 1, 2026, following the communication of its financial results for the quarter and year ended March 31, 2026. The window was previously closed on March 30, 2026, to comply with insider trading regulations ahead of the results announcement. The company confirmed that the results have now been submitted to the stock exchanges, allowing the trading window to reopen after the mandatory 48-hour period post-disclosure.

The closure of the trading window was a procedural measure implemented to prevent insider trading while the financial results were being finalized. The restriction applied to insiders and designated persons associated with Alkem Laboratories . The reopening of the window permits these individuals to trade in the company's securities once again.

Event Date
Trading Window Closure March 30, 2026
Financial Results Communication May 28, 2026
Trading Window Opening June 1, 2026

The intimation was addressed to the Corporate Relationship Department of BSE Limited and the National Stock Exchange of India Limited. The filing was signed by Manish Narang, President - Legal, Company Secretary & Compliance Officer of Alkem Laboratories Limited.

Historical Stock Returns for Alkem Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.85%+1.13%+2.88%-3.31%+4.41%+87.36%

How will the market react to the financial results now that the trading window has reopened?

What trends in insider trading activity might emerge following the lifting of the restriction?

Could the reopening of the trading window signal a shift in Alkem Laboratories' stock performance in the near term?

Alkem Laboratories releases Q4FY26 and FY26 earnings call audio

1 min read     Updated on 29 May 2026, 03:38 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Alkem Laboratories Limited has released the audio recording of its Q4FY26 and FY26 earnings conference call on its website. The disclosure complies with SEBI regulations and was signed by Manish Narang, President – Legal, Company Secretary & Compliance Officer. The recording is accessible to investors via the company's investor relations portal.

powered bylight_fuzz_icon
41551676

*this image is generated using AI for illustrative purposes only.

Alkem Laboratories Limited has released the audio recording of its Q4FY26 and FY26 earnings conference call. The recording is now available for investors and shareholders on the company’s official website. This disclosure ensures that all market participants have equal access to the management's commentary on the financial performance for the reported periods.

The filing was submitted to the stock exchanges in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication was addressed to the Corporate Relationship Departments of BSE Limited and National Stock Exchange of India Limited. The company’s scrip is traded under the code 539523 on the BSE and the symbol ALKEM on the NSE.

Manish Narang, President – Legal, Company Secretary & Compliance Officer, signed the disclosure on behalf of Alkem Laboratories Limited . The document confirmed that the audio file has been uploaded to the dedicated investors section of the corporate portal. The move aligns with standard regulatory practices for post-results transparency.

Exchange Entity Identifier
BSE Limited BSE Limited 539523
National Stock Exchange of India Limited ALKEM ALKEM

The earnings call provides insights into the operational and financial results for the fourth quarter and the full financial year ending March 31, 2026. Stakeholders can review the discussion to understand the factors driving the company's performance during these periods.

Historical Stock Returns for Alkem Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+0.85%+1.13%+2.88%-3.31%+4.41%+87.36%

What are the key growth drivers Alkem management anticipates for the upcoming fiscal year following the FY26 results?

How might the company's capital allocation strategy shift based on the financial performance discussed in the call?

What impact could recent regulatory changes in the pharmaceutical sector have on Alkem's future margins?

More News on Alkem Laboratories

1 Year Returns:+4.41%